Full Description
This book offers a comprehensive overview of the latest breakthroughs transforming cancer research and treatment. Integrating insights from molecular biology, pharmacology, microbiomics, and artificial intelligence, this volume highlights how cross-disciplinary innovations are redefining oncology.
The book explores the applications of multi-omics and computational tools, the potential of heterocyclic and bioactive compounds, and the promise of probiotic-based nanomedicine in advancing personalized cancer therapy. It further examines the emerging roles of the gut microbiome, pharmacomicrobiomics, and AI-driven diagnostics in enhancing therapeutic precision and enabling early cancer detection. Addressing a wide spectrum of cancer types from colorectal and breast cancers to gliomas, the book also discusses contemporary challenges such as microplastic exposure, mitochondrial dysfunction, and the importance of evidence-based clinical practices in oncology. Beyond therapeutics, it highlights cutting-edge diagnostic innovations, including AI-assisted screening tools and microbiome-based biomarkers for early colorectal cancer detection. The volume concludes with evidence-based insights into clinical practices, such as blood transfusion protocols in oncology, effectively bridging laboratory research with real-world clinical applications.
With contributions from leading experts across disciplines, this book serves as a valuable reference for oncologists, biomedical researchers, clinicians, and students, offering a forward-looking perspective on how integrated scientific approaches are shaping the future of cancer care.
Contents
Chapter 1: Multi-Omics, Computational Approaches, and AI Tools in Oncotherapeutics: Recent Advances and Perspectives. Chapter 2: Exploring Small Heterocyclic Compounds as Promising Agents in Cancer Therapy. Chapter 3: Probiotic-Based Nanomedicine: A Next-Generation Strategy for Personalized Cancer Therapy. Chapter 4: Pharmacomicrobiomics and AI designs in GI Tract Cancers. Chapter 5: Gut microbiome: a novel screening tool for colorectal cancer. Chapter 6: The Intersection of Oncology and Infectious Diseases in Human Health: The Battle Between Pathogens. Chapter 7: Artificial intelligence-integrated precision oncology of colorectal cancer. Chapter 8: Precision Medicine in Breast Cancer: An Immuno-oncology Approach. Chapter 9: Harnessing probiotics for personalized cancer therapy: A holistic approach. Chapter 10: Mitochondrial Dysfunction in Gliomas: Pathophysiological insights and Therapeutic Targets. Chapter 11: Plastic Pollution and Cancer: The Emerging Role of Microplastics in Oncology. Chapter 12: Bioactive Compounds in Personalized Colorectal Cancer Therapy: Emerging Challenges and Future Directions. Chapter 13: Evidence based blood transfusion practices.
